Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
6 citing papers in PubMed, 14 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 4 institutions in 3 countries.
Vincenzo RazzanoDipartimento di Biotecnologie, Chimica e Farmacia, European Research Centre for Drug Discovery and Development, Università di Siena Via A. Moro 2 53100 Siena Italy andrea.cappelli@unisi.it vincy_box@hotmail.it paomar@oneonline.it reale5@student.unisi.it germix67@hotmail.com alessandro.donati@unisi.it gianluca.giorgi@unisi.it +39 577 234320.ORCID https://orcid.org/0000-0001-6299-4504
Marco PaolinoDipartimento di Biotecnologie, Chimica e Farmacia, European Research Centre for Drug Discovery and Development, Università di Siena Via A. Moro 2 53100 Siena Italy andrea.cappelli@unisi.it vincy_box@hotmail.it paomar@oneonline.it reale5@student.unisi.it germix67@hotmail.com alessandro.donati@unisi.it gianluca.giorgi@unisi.it +39 577 234320.ORCID https://orcid.org/0000-0003-1387-7875
Annalisa RealeDipartimento di Biotecnologie, Chimica e Farmacia, European Research Centre for Drug Discovery and Development, Università di Siena Via A. Moro 2 53100 Siena Italy andrea.cappelli@unisi.it vincy_box@hotmail.it paomar@oneonline.it reale5@student.unisi.it germix67@hotmail.com alessandro.donati@unisi.it gianluca.giorgi@unisi.it +39 577 234320.ORCID https://orcid.org/0000-0001-6687-186X
Germano GiulianiDipartimento di Biotecnologie, Chimica e Farmacia, European Research Centre for Drug Discovery and Development, Università di Siena Via A. Moro 2 53100 Siena Italy andrea.cappelli@unisi.it vincy_box@hotmail.it paomar@oneonline.it reale5@student.unisi.it germix67@hotmail.com alessandro.donati@unisi.it gianluca.giorgi@unisi.it +39 577 234320.
Alessandro DonatiDipartimento di Biotecnologie, Chimica e Farmacia, European Research Centre for Drug Discovery and Development, Università di Siena Via A. Moro 2 53100 Siena Italy andrea.cappelli@unisi.it vincy_box@hotmail.it paomar@oneonline.it reale5@student.unisi.it germix67@hotmail.com alessandro.donati@unisi.it gianluca.giorgi@unisi.it +39 577 234320.
Gianluca GiorgiDipartimento di Biotecnologie, Chimica e Farmacia, European Research Centre for Drug Discovery and Development, Università di Siena Via A. Moro 2 53100 Siena Italy andrea.cappelli@unisi.it vincy_box@hotmail.it paomar@oneonline.it reale5@student.unisi.it germix67@hotmail.com alessandro.donati@unisi.it gianluca.giorgi@unisi.it +39 577 234320.
Roberto ArtusiRottapharm Biotech S.p.A. Via Valosa di Sopra 9 20900 Monza Italy Roberto.Artusi@rottapharmbiotech.com Gianfranco.Caselli@rottapharmbiotech.com Michela.Visintin@rottapharmbiotech.com Francesco.Makovec@rottapharmbiotech.com.
Gianfranco CaselliRottapharm Biotech S.p.A. Via Valosa di Sopra 9 20900 Monza Italy Roberto.Artusi@rottapharmbiotech.com Gianfranco.Caselli@rottapharmbiotech.com Michela.Visintin@rottapharmbiotech.com Francesco.Makovec@rottapharmbiotech.com.ORCID https://orcid.org/0000-0002-1075-7408
Michela VisintinRottapharm Biotech S.p.A. Via Valosa di Sopra 9 20900 Monza Italy Roberto.Artusi@rottapharmbiotech.com Gianfranco.Caselli@rottapharmbiotech.com Michela.Visintin@rottapharmbiotech.com Francesco.Makovec@rottapharmbiotech.com.ORCID https://orcid.org/0000-0003-3490-6807
Francesco MakovecRottapharm Biotech S.p.A. Via Valosa di Sopra 9 20900 Monza Italy Roberto.Artusi@rottapharmbiotech.com Gianfranco.Caselli@rottapharmbiotech.com Michela.Visintin@rottapharmbiotech.com Francesco.Makovec@rottapharmbiotech.com.
Salvatore BattiatoIstituto per i Polimeri, Compositi e Biomateriali (IPCB), U.O.S. di Catania, CNR Via Gaifami 18 95126 Catania Italy salvatore.battiato@cnr.it fsamperi@unict.it.ORCID https://orcid.org/0000-0002-0657-1408
Filippo SamperiIstituto per i Polimeri, Compositi e Biomateriali (IPCB), U.O.S. di Catania, CNR Via Gaifami 18 95126 Catania Italy salvatore.battiato@cnr.it fsamperi@unict.it.ORCID https://orcid.org/0000-0002-8941-1812
Francesca Villafiorita-MonteleoneIstituto per lo Studio delle Macromolecole (CNR) Via A. Corti 12 20133 Milano Italy villafiorita@ismac.cnr.it chiara.botta@ismac.cnr.it.ORCID https://orcid.org/0000-0002-2302-6698
Chiara BottaIstituto per lo Studio delle Macromolecole (CNR) Via A. Corti 12 20133 Milano Italy villafiorita@ismac.cnr.it chiara.botta@ismac.cnr.it.ORCID https://orcid.org/0000-0001-8722-0417
Andrea CappelliDipartimento di Biotecnologie, Chimica e Farmacia, European Research Centre for Drug Discovery and Development, Università di Siena Via A. Moro 2 53100 Siena Italy andrea.cappelli@unisi.it vincy_box@hotmail.it paomar@oneonline.it reale5@student.unisi.it germix67@hotmail.com alessandro.donati@unisi.it gianluca.giorgi@unisi.it +39 577 234320.ORCID https://orcid.org/0000-0003-4140-3028
University of Siena · ITBiotech Park · INMylan (South Africa) · ZAUniversity of Catania · IT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
A small series of Morita-Baylis-Hillman adduct (MBHA) derivatives was synthesized and made to react with imidazole,
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Poly-histidine grafting leading to fishbone-like architectures. · full record | OpenQuestion